Disc Medicine, Inc.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
IRON$81.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| June 30,2025 | December 31,2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $127,337 | $192,434 |
| Marketable securities | 522,636 | 297,447 |
| Prepaid expenses and other current assets | 11,619 | 3,734 |
| Total current assets | 661,592 | 493,615 |
| Property and equipment, net | 1,289 | 751 |
| Right-of-use assets, operating leases | 1,340 | 1,569 |
| Other assets | 840 | 838 |
| Total assets | $665,061 | $496,773 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $6,350 | $7,948 |
| Accrued external research and development expenses | 7,463 | 7,141 |
| Other accrued expenses | 6,161 | 8,097 |
| Operating lease liabilities, current | 632 | 130 |
| Total current liabilities | 20,606 | 23,316 |
| Long-term debt, net | 28,737 | 28,322 |
| Operating lease liabilities, non-current | 1,553 | 1,548 |
| Total liabilities | 50,896 | 53,186 |
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of June 30, 2025 and December 31, 2024 | — | — |
| Common stock, $0.0001 par value; 100,000,000 shares authorized as of June 30, 2025 and December 31, 2024; 34,694,882 and 29,865,030 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 3 | 3 |
| Additional paid-in capital | 1,001,223 | 741,297 |
| Accumulated other comprehensive income | 273 | 289 |
| Accumulated deficit | (387,334) | (298,002) |
| Total stockholders’ equity | 614,165 | 443,587 |
| Total liabilities and stockholders’ equity | $665,061 | $496,773 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.